AN1 0.00% 0.8¢ anagenics limited

Ann: Appendix 4C and Quarterly Activity Report, page-2

  1. 1,286 Posts.
    lightbulb Created with Sketch. 243
    Evolis sales virtually nonexistent, staff reductions in Evolis?, probably why my periodic order hasn't been delivered.
    Great appointment in the UPSA acquisition.
    This statement, "currently in due diligence on multiple opportunities" these multiple opportunities must be with the collapse of BWX.
    I like what I'm seeing as it's what I would be doing, although the numbers are still not pretty.
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.